Clinical features of patients | N or Mean (SD or %) | |
---|---|---|
Age | 68.5 (11.4) | |
Gender | ||
Male | 51 (89.4) | |
Female | 6 (10.6) | |
Disease history | ||
Primary | 31 (54.4) | |
Recurrent | 26 (45.6) | |
Smokers | 37 (64.9) | |
Diabetes | 10 (17.5) | |
Hypertension | 34 (59.7) | |
Stage | ||
Ta | 35 (61.4) | |
T1 | 22 (38.6) | |
Multifocality | ||
Not | 16 (28.1) | |
Yes | 41 (71.9) | |
Tumor size > 3 cm | 27 (47.4) | |
Carcinoma in situ | 4 (7%) | |
EORTC score for progression | ||
Mean value | 9.8 (4.9) | |
Risk class 1 (2–6) | 15 (26.4) | |
Risk class 2 (7–13) | 29 (50.8) | |
Risk class 3 (14–23) | 13 (22.8) | |
Characteristics of healthy controls | Urine Samples | Tissue Samples |
N or Mean (SD or %) | ||
Total Number | 20 | 10 |
Age (years) | 62.2 (10.1) | 69.8 (11) |
Gender | ||
Male | 17 (85) | 7 (70) |
Female | 3 (15) | 3 (30) |